Phase 2 Depression and Anxiety Trial, Recruiting NCT05002309 Sponsor: Nova Scotia Health Authority Condition: Depression and Anxiety
Back to Depression And Anxiety

Phase 2 Depression and Anxiety Trial, Recruiting

NCT05002309
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 12 and 25 years old
  • You have been diagnosed with major depression, and that diagnosis was made within the last 12 months, with depression being your most pressing problem needing treatment
  • Your depression is at least moderate in severity (as measured by specific rating scales) if you want to take part in the active treatment stage — if your depression scores are lower, you may still be able to take part in follow-up check-ins
  • You are able to talk and communicate well enough to take part in talking-based therapy

Who may not be able to join:

  • You have a personal history of manic or hypomanic episodes, psychosis, autism spectrum disorder, a developmental disability, an intellectual disability, a mental health condition caused by a neurological or other physical illness, or a current serious substance use problem
  • You have previously received any treatment specifically for depression that lasted 4 weeks or longer, or you are currently taking antipsychotic, antidepressant, or mood-stabilising medication
  • You have had a change in any mental health medication (including sleep, anxiety, or stimulant medications) in the past 6 weeks, or you have already completed 4 or more sessions of cognitive-behavioural therapy
  • You are currently pregnant or breastfeeding (confirm with trial site for further details on how this is handled during the study)
  • No one will be turned away based on sex, gender, race, ethnicity, or living situation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Rudolf Uher, MD, PhD, Nova Scotia Health Authority

Phone: 902-473-7209

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Nova Scotia Health Authority
Registry
ClinicalTrials.gov
Start date
2 December 2021
Est. completion
30 June 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Severity of depressive symptoms; Severity of depressive symptoms; Proportion of time spent depression free

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov